Franklin D. Lowy
- Clinical Biochemistry top 0.1%
- Bacterial Identification and Susceptibility Testing 29
- Infectious Diseases top 0.2%
- Antimicrobial Resistance in Staphylococcus 65
- Clostridium difficile and Clostridium perfringens research 13
- Microbiology top 0.5%
- Molecular Medicine top 0.5%
-
- Bacterial biofilms and quorum sensing 27
- Biochemical and Structural Characterization 6
-
- Streptococcal Infections and Treatments 17
-
- Orthopedic Infections and Treatments 6
-
- Mycobacterium research and diagnosis 6
- Co-authors
- Rachel GordonAnne‐Catrin UhlemannE. Yoko FuruyaSharon J. PeacockMaureen MillerElaine LarsonJustin KnoxCarlos Arrecubieta
- Journals
- Clinical Infectious Diseases (7 papers)The Journal of Infectious Diseases (7 papers)PLoS ONE (4 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Franklin D. Lowy
93 papers receiving 6.7k citations
Hit Papers
Peers
Comparison fields: 5 of 182
- Clinical Biochemistry 1.5k
- Infectious Diseases 4.0k
- Applied Microbiology and Biotechnology 215
- Microbiology 654
- Molecular Medicine 514
Countries citing papers authored by Franklin D. Lowy
This map shows the geographic impact of Franklin D. Lowy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franklin D. Lowy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franklin D. Lowy more than expected).
Fields of papers citing papers by Franklin D. Lowy
This network shows the impact of papers produced by Franklin D. Lowy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franklin D. Lowy. The network helps show where Franklin D. Lowy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Franklin D. Lowy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 35 | |
| 2 | 2016 | 14 | |
| 3 | 2015 | 41 | |
| 4 | 2015 | 4 | |
| 5 | 2014 | 118 | |
| 6 | 2014 | 28 | |
| 7 | 2011 | 32 | |
| 8 | 2011 | 77 | |
| 9 | 2010 | 15 | |
| 10 | 2009 | 27 | |
| 11 | 2009 | 68 | |
| 12 | 2007 | 13 | |
| 13 | 2005 | 108 | |
| 14 | 2005 | 231 | |
| 15 | Antimicrobial resistance: the example of Staphylococcus aureusbreakdown → | 2003 | 1111 |
| 16 | 2002 | 37 | |
| 17 | 2000 | 154 | |
| 18 | 1998 | 6 | |
| 19 | 1996 | 34 | |
| 20 | 1987 | 24 |
About Franklin D. Lowy
Franklin D. Lowy is a scholar working on Clinical Biochemistry, Infectious Diseases and Applied Microbiology and Biotechnology, having authored 94 papers that have together received 7.0k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (65 papers), Bacterial Identification and Susceptibility Testing (29 papers), Bacterial biofilms and quorum sensing (27 papers), Streptococcal Infections and Treatments (17 papers), Clostridium difficile and Clostridium perfringens research (13 papers), Orthopedic Infections and Treatments (6 papers), Mycobacterium research and diagnosis (6 papers) and Biochemical and Structural Characterization (6 papers). The work is most often cited by research in Clinical Biochemistry (1.5k citations), Infectious Diseases (4.0k citations) and Applied Microbiology and Biotechnology (215 citations). Franklin D. Lowy has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Rachel Gordon, Anne‐Catrin Uhlemann, E. Yoko Furuya, Sharon J. Peacock, Maureen Miller, Elaine Larson, Justin Knox, Carlos Arrecubieta, Peter Vavagiakis and Frank R. DeLeo. Their work appears in journals such as Clinical Infectious Diseases, The Journal of Infectious Diseases, PLoS ONE, Journal of Clinical Microbiology and American Journal of Infection Control.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.